Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Aggressive B-cell Lymphoma
28:25

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Does RCHOP Stay the Standard of Care After 6 Cycles in Advanced/R DLBCL? + Drug X Strategy

FEATURING Anas Younes
  • 280 views
  • October 18, 2019
15:02

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Overview of CD19 Directed CAR-T in DLBCL: Tisagenleucel, Axicabtagene Ciloleucel, and Lisocabtagene Maraleucel

FEATURING David Maloney
  • 482 views
  • October 18, 2019
  • 1
23:38

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Ongoing Efforts to Improve the Safety of CAR T-Cell Therapy: Cytokine Release Syndrome and Neurotoxicity

FEATURING Bianca Santomasso
  • 20 views
  • October 16, 2019
11:16

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Correlative Analyses of Cytokine Release Syndrome and Neurological Events in Tisagenlecleucel-Treated Relapsed/Refractory DLBCL

FEATURING Jason Westin
  • 14 views
  • October 18, 2019
07:27

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Plasmablastic Lymphoma: Survival Analysis of a SEER Database (2010-2016) - Demographic / Clinical Characteristics, OS and Lymphoma-Specific / HIV-Specific Survival

FEATURING Jorge Florindez
  • 17 views
  • October 18, 2019
08:16

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory DLBCL

FEATURING Michael Schuster
  • 19 views
  • October 18, 2019